Target intelligence / Profile preview

BH3-only and pro-apoptotic BCL-2 family proteins (BH3-only proteins)

Target
BH3-only proteins
Molecular classification
BCL-2 family, Pro-apoptotic proteins, Intracellular signaling proteins, Mitochondrial membrane-associated proteins
01

Overview

BH3-only and pro-apoptotic BCL-2 family proteins are critical regulators of the intrinsic (mitochondrial) pathway of apoptosis, serving as sensors of cellular stress and executioners of programmed cell death [Source: PubMed, UniProt]. This functional group includes activator and sensitizer BH3-only proteins, such as BIM, BID, PUMA, and NOXA, as well as the effector proteins BAX and BAK, which directly mediate mitochondrial outer membrane permeabilization (MOMP) [Source: Nature Reviews Molecular Cell Biology]. These proteins respond to various stress signals, including DNA damage and growth factor withdrawal, by initiating a cascade that leads to the release of cytochrome c from the mitochondria [Source: NIH]. In many cancers, the activity of these pro-apoptotic proteins is neutralized by the overexpression of anti-apoptotic BCL-2 family members, which sequester them to prevent cell death and promote tumor survival [Source: Cell Death & Differentiation]. Therapeutic intervention primarily involves BH3 mimetics, such as Venetoclax, which are small molecules designed to mimic the BH3 domain of pro-apoptotic proteins to inhibit anti-apoptotic proteins and restore the apoptotic signal [Source: FDA, PubMed]. These targets are pivotal in the treatment of hematologic malignancies and are currently being explored for their potential in treating various solid tumors [Source: PubMed].

Other names
BH3-only proteinsPro-apoptotic BCL-2 family membersBCL-2 homology 3-only proteinsApoptotic activators and sensitizersBAX/BAK-like proteins
02

Mechanism of action

BH3 mimetics function by binding to the hydrophobic surface groove of anti-apoptotic BCL-2 family proteins (e.g., BCL-2, BCL-XL, MCL-1), which normally sequester pro-apoptotic BH3-only proteins and effectors like BAX and BAK [Source: PubMed]. By occupying this groove, the drugs displace the pro-apoptotic proteins, allowing BAX and BAK to undergo conformational changes, oligomerize, and form pores in the mitochondrial outer membrane [Source: Nature Reviews]. This process, known as mitochondrial outer membrane permeabilization (MOMP), leads to the release of cytochrome c and other pro-apoptotic factors into the cytosol, activating the caspase cascade and resulting in rapid cell death [Source: UniProt].

03

Biological functions

ApoptosisMitochondrial outer membrane permeabilization (MOMP)Cell death regulationResponse to DNA damageSignal transduction
04

Disease associations

CancerChronic lymphocytic leukemia (CLL)Acute myeloid leukemia (AML)Multiple myelomaAutoimmune disordersNeurodegenerative diseases
05

Safety considerations

Tumor lysis syndrome (TLS)Thrombocytopenia (associated with BCL-XL inhibition)NeutropeniaGastrointestinal toxicityIncreased risk of infection
06

Interacting drugs

Venetoclax

8 more in the full profile.

07

Biomarkers

BCL-2 expression levelsBH3 profiling (mitochondrial priming)BIM protein levelsBAX/BAK expression statusMCL-1 gene amplification

Beyond the preview

Go deeper on BH3-only and pro-apoptotic BCL-2 family proteins (BH3-only proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BH3-only and pro-apoptotic BCL-2 family proteins (BH3-only proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call